Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders |
Limoneira CO (LMNR)
|
Add to portfolio |
|
|
Price: |
$18.21
| | Metrics |
OS: |
18.0
|
M
| |
9
|
% ROE
|
Market cap: |
$327
|
M
| |
-4
|
% ROIC
|
Net debt:
|
$31.4
|
M
| |
|
|
EV:
|
$359
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($571.0)
|
k
| |
|
|
EBIT
|
($9.9)
|
M
| |
|
|
EPS |
$0.98
| |
18.6
|
x P/E
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Oct-31-22 | Oct-31-21 | Oct-31-20 | Oct-31-19 | Oct-31-18 | Oct-31-17 | Oct-31-16 | Oct-31-15 |
Revenues | 184.6 | 166.0 | 164.6 | 171.4 | 129.4 | 121.3 | 111.8 | 100.3 |
Revenue growth | 11.2% | 0.9% | -4.0% | 32.5% | 6.7% | 8.5% | 11.4% | -3.0% |
Cost of goods sold | 165.1 | 152.8 | 161.8 | 156.8 | 102.3 | 3.9 | 3.6 | 80.6 |
Gross profit | 19.5 | 13.2 | 2.8 | 14.6 | 27.1 | 117.4 | 108.2 | 19.7 |
Gross margin | 10.6% | 8.0% | 1.7% | 8.5% | 20.9% | 96.8% | 96.8% | 19.6% |
Selling, general and administrative | 21.8 | 19.4 | 21.3 | 21.2 | 16.1 | 13.9 | 13.3 | 13.8 |
EBITA | -4.7 | -2.0 | -16.7 | -1.8 | 11.7 | 12.1 | 10.9 | 4.9 |
EBITA margin | -2.6% | -1.2% | -10.1% | -1.0% | 9.1% | 10.0% | 9.8% | 4.9% |
Amortization of intangibles | 0.7 | 0.9 | 1.0 | 0.7 | 0.1 | 0.1 | 0.1 | 0.1 |
EBIT | -5.5 | -2.9 | -17.7 | -2.4 | 11.6 | 12.0 | 10.8 | 4.8 |
EBIT margin | -3.0% | -1.8% | -10.7% | -1.4% | 9.0% | 9.9% | 9.7% | 4.8% |
Pre-tax income | 0.3 | -4.2 | -26.4 | -6.6 | 13.5 | 10.6 | 13.3 | 11.1 |
Income taxes | 0.8 | -0.3 | -8.5 | -1.1 | -6.7 | 4.1 | 5.3 | 4.0 |
Tax rate | 235.8% | 6.4% | 32.1% | 16.7% | | 38.4% | 39.5% | 35.9% |
Net income | -0.7 | -3.9 | -16.9 | -6.4 | 19.7 | 6.0 | 7.4 | 6.4 |
Net margin | -0.4% | -2.4% | -10.3% | -3.8% | 15.2% | 5.0% | 6.6% | 6.4% |
|
Diluted EPS | ($0.04) | ($0.22) | ($0.96) | ($0.37) | $1.21 | $0.42 | $0.52 | $0.46 |
Shares outstanding (diluted) | 17.5 | 17.6 | 17.7 | 17.6 | 16.2 | 14.3 | 14.2 | 14.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|